<?xml version="1.0" encoding="UTF-8"?>
<p>The process developed represents a collaborative and robust approach to assist in informing regional critical care drug requirements in response to the COVID-19 pandemic. Further application has been demonstrated in regional procurement planning and preparedness. It is anticipated that the complexity and robustness of the model will increase and will be further refined based on evolving real-world data.</p>
